US COMPANY TO SELL CELL-CULTURE FLU VACCINE
July 5th, 2014
Novartis Vaccines is now selling the United States’ first cell-culture influenza vaccine, after the US Food and Drug Administration (FDA) licensed Novartis’ manufacturing facility in Holly Springs, North Carolina in June. The company’s technology uses mammalian animal cells – a method called cell-culture technology – to produce the vaccine, rather than the traditional method that takes place in chickens’ eggs. The main advantage of cell-culture technology, according to Novartis, is that the manufacturing process is more easily controlled and can ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.